BMY

Bristol-Myers Squibb (BMY) Stock Analysis: Potential Upside and Dividend Yield Attract Investor Interest

Bristol-Myers Squibb Company (NYSE: BMY), a titan in the healthcare sector, particularly in drug manufacturing, continues to hold investor attention with its solid dividend yield and..

Bristol-Myers Squibb (BMY) Stock Analysis: Is the Nearly 5% Dividend Yield a Reason to Buy?

Bristol-Myers Squibb Company (BMY), a heavyweight in the healthcare sector, operates within the dynamic drug manufacturing industry. With a market capitalization of $101.37 billion, this U.S.-based..

Bristol-Myers Squibb (BMY): Potential 19.73% Upside Amidst Strong Dividend Yield

Bristol-Myers Squibb Company (BMY), a titan in the healthcare sector, has long been a staple in the portfolios of investors seeking exposure to biopharmaceutical innovation. With..

Bristol-Myers Squibb (BMY) Offers a 14.24% Potential Upside: Is It Time to Invest?

Bristol-Myers Squibb Company (NYSE: BMY), a titan in the healthcare sector, stands as a compelling investment opportunity with a potential upside of 14.24%. With a market..

Bristol-Myers Squibb (BMY): A Healthcare Giant with a 4.16% Dividend Yield and Promising Upside

Bristol-Myers Squibb Company (NYSE: BMY), a titan in the healthcare sector, continues to capture investor attention with its robust biopharmaceutical portfolio and attractive dividend yield. With..

Bristol-Myers Squibb (BMY): A Healthcare Giant with a 4.19% Dividend Yield and Growth Potential

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, stands as a formidable player within the biopharmaceutical landscape. With a market capitalization of $120.11..

Bristol-Myers Squibb Company Share Price Target ‘$61.24’, now 2.3% Upside Potential

Bristol-Myers Squibb Company which can be found using ticker (BMY) have now 21 confirmed analysts covering the stock with the consensus suggesting a rating of ‘hold’...

Bristol-Myers Squibb Company Share Price Target ‘$61.34’, now 6.0% Upside Potential

Bristol-Myers Squibb Company which can be found using ticker (BMY) have now 21 market analysts covering the stock. The analyst consensus now points to a rating..

Bristol-Myers Squibb Company Share Price Target ‘$61.34’, now 12.7% Upside Potential

Bristol-Myers Squibb Company with ticker code (BMY) now have 21 market analysts covering the stock. The analyst consensus now points to a rating of ‘hold’. The..

Bristol-Myers Squibb Company – Consensus ‘hold’ rating and 9.1% Upside Potential

Bristol-Myers Squibb Company which can be found using ticker (BMY) have now 21 analysts in total covering the stock. The consensus rating is pointing to ‘hold’...

Bristol-Myers Squibb Company – Consensus ‘hold’ rating and 4.1% Upside Potential

Bristol-Myers Squibb Company which can be found using ticker (BMY) have now 21 analysts in total covering the stock. The consensus rating is pointing to ‘hold’...

Bloomsbury Publishing Plc reaches new long term supply agreement with Amazon

Bloomsbury Publishing Plc secures a landmark long-term supply agreement with Amazon, reaffirming expected growth and market confidence for 2025...

Bristol-Myers Squibb Company – Consensus ‘hold’ rating and 8.4% Upside Potential

Bristol-Myers Squibb Company which can be found using ticker (BMY) now have 21 market analysts covering the stock. The analyst consensus now points to a rating..

Bristol-Myers Squibb Company – Consensus ‘hold’ rating and 9.1% Upside Potential

Bristol-Myers Squibb Company which can be found using ticker (BMY) have now 21 confirmed analysts covering the stock with the consensus suggesting a rating of ‘hold’...

Bristol-Myers Squibb Company Share Price Target ‘$61.05’, now 7.7% Upside Potential

Bristol-Myers Squibb Company with ticker code (BMY) have now 21 confirmed analysts covering the stock with the consensus suggesting a rating of ‘hold’. The range between..

Bristol-Myers Squibb Company – Consensus ‘hold’ rating and 7.7% Upside Potential

Bristol-Myers Squibb Company which can be found using ticker (BMY) now have 21 analysts in total covering the stock. The consensus rating is pointing to ‘hold’...

Bristol-Myers Squibb Company Share Price Target ‘$60.91’, now 6.2% Upside Potential

Bristol-Myers Squibb Company which can be found using ticker (BMY) now have 21 analysts in total covering the stock. The consensus rating is pointing to ‘hold’...

Bristol-Myers Squibb Company Share Price Target ‘$60.58’, now 6.9% Upside Potential

Bristol-Myers Squibb Company which can be found using ticker (BMY) have now 21 analysts in total covering the stock. The consensus rating is pointing to ‘hold’...

Bristol-Myers Squibb Company – Consensus ‘hold’ rating and 2.7% Upside Potential

Bristol-Myers Squibb Company which can be found using ticker (BMY) have now 21 analysts in total covering the stock. The consensus rating is pointing to ‘hold’...

Bristol-Myers Squibb Company – Consensus ‘hold’ rating and 2.0% Upside Potential

Bristol-Myers Squibb Company which can be found using ticker (BMY) have now 21 confirmed analysts covering the stock with the consensus suggesting a rating of ‘hold’...

Search

Funds

BMY

Bloomsbury Publishing Plc reaches new long term supply agreement with Amazon

Bloomsbury Publishing Plc secures a landmark long-term supply agreement with Amazon, reaffirming expected growth and market confidence for 2025...
Search

Funds

BMY

FTSE 100

Funds